ACROPASS ACNE CURE patch

ACROPASS ACNE CURE by

Drug Labeling and Warnings

ACROPASS ACNE CURE by is a Otc medication manufactured, distributed, or labeled by RAPHAS CO., LTD, RAPHAS CO.,LTD. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Active Ingredients Purpose

Salicylic Acid 2%.................................................... Acne Treatment

PURPOSE

Uses: For the treatment of acnes

WARNINGS

For external use only

WHEN USING

• Skin irritation and dryness may occur if you use another topical acne medication at the same time or immediately following.
• If irritation occurs, only use one topical acne medication at a time unless directed by doctor.

STOP USE

if irritation becomes severe.

ASK DOCTOR

if irritation becomes severe.

KEEP OUT OF REACH OF CHILDREN

if swallowed, get medical help or contact a Poison Control Center right away.

STORAGE AND HANDLING

Store at room temperature. Avoid use if you have very sensitive skin or anr allergic to Salicylic acid.

INACTIVE INGREDIENT

Sodium Hyaluronate, Niacinamide, Oligopeptide-10, Phytosphingosine HCl

Patch : Hydrocolloid

REFERENCES

DOSAGE & ADMINISTRATION

1. Open the packaging and take out the patch.
2. Carefully remove the white film, ensuring not to touch the center of the patch.
3. Apply the patch directly to the affected area and press vertically with your fingers.
4. Leave on for 2 hours or overnight, then remove.

INDICATIONS & USAGE

1. Open the packaging and take out the patch.
2. Carefully remove the white film, ensuring not to touch the center of the patch.
3. Apply the patch directly to the affected area and press vertically with your fingers.
4. Leave on for 2 hours or overnight, then remove.

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

ACROPASS ACNE CURE 
acropass acne cure patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 71134-241
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.012 mg  in 0.6013 mg

Inactive Ingredients
Ingredient Name	Strength
PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU)
NIACINAMIDE (UNII: 25X51I8RD4)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
OLIGOPEPTIDE-10 (UNII: Q46328TRNK)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 71134-241-01	4 mg in 1 BOX; Type 0: Not a Combination Product	08/28/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	08/28/2024

Labeler - RAPHAS CO., LTD (689054529)

Establishment
Name	Address	ID/FEI	Business Operations
RAPHAS CO.,LTD		695914964	manufacture(71134-241)